Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prime Medicine (PRME) Amortization - Intangibles (2023 - 2025)

Prime Medicine (PRME) has disclosed Amortization - Intangibles for 3 consecutive years, with $858000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization - Intangibles rose 180.39% year-over-year to $858000.0, compared with a TTM value of $2.5 million through Dec 2025, down 29.31%, and an annual FY2025 reading of $2.5 million, down 29.31% over the prior year.
  • Amortization - Intangibles was $858000.0 for Q4 2025 at Prime Medicine, up from $752000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $1.8 million in Q3 2023 and bottomed at $306000.0 in Q4 2024.
  • Average Amortization - Intangibles over 3 years is $888100.0, with a median of $844000.0 recorded in 2024.
  • The sharpest move saw Amortization - Intangibles plummeted 72.82% in 2024, then soared 180.39% in 2025.
  • Year by year, Amortization - Intangibles stood at $1.1 million in 2023, then tumbled by 72.82% to $306000.0 in 2024, then surged by 180.39% to $858000.0 in 2025.
  • Business Quant data shows Amortization - Intangibles for PRME at $858000.0 in Q4 2025, $752000.0 in Q3 2025, and $530000.0 in Q2 2025.